MX9305196A - Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso. - Google Patents

Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso.

Info

Publication number
MX9305196A
MX9305196A MX9305196A MX9305196A MX9305196A MX 9305196 A MX9305196 A MX 9305196A MX 9305196 A MX9305196 A MX 9305196A MX 9305196 A MX9305196 A MX 9305196A MX 9305196 A MX9305196 A MX 9305196A
Authority
MX
Mexico
Prior art keywords
compositions
novel
sacarinyl
methods
proteolytic enzyme
Prior art date
Application number
MX9305196A
Other languages
English (en)
Inventor
Virendra Kumar
Dennis John Hlasta
Malcolm Rice Bell
John Joseph Court
Chakrapani Subramanyam
Ranjit Chimanlal Desai
Richard Paul Dunlap
Beil Warren Boaz
Albert Joseph Mura
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of MX9305196A publication Critical patent/MX9305196A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)

Abstract

4-R4-R5-2-Sacarinimetil aril carboxilatos, útiles en el tratamiento de enfermedades degenerativas, se preparan al reaccionar 4-R4-R5-2-halometilsacarian con un ácido arilcarboxílico en la presencia de un aceptor de ácido.
MX9305196A 1992-10-23 1993-09-26 Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso. MX9305196A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/965,593 US5306818A (en) 1990-11-01 1992-10-23 Tetrahydro 2-saccharinylmerthyl aryl carboxylates

Publications (1)

Publication Number Publication Date
MX9305196A true MX9305196A (es) 1994-05-31

Family

ID=25510194

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305196A MX9305196A (es) 1992-10-23 1993-09-26 Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso.

Country Status (22)

Country Link
US (1) US5306818A (es)
EP (1) EP0594257B1 (es)
JP (1) JPH06211849A (es)
KR (1) KR940009183A (es)
AT (1) ATE140227T1 (es)
AU (1) AU679446B2 (es)
CA (1) CA2105731A1 (es)
CZ (1) CZ221093A3 (es)
DE (1) DE69303573T2 (es)
DK (1) DK0594257T3 (es)
ES (1) ES2092751T3 (es)
FI (1) FI934675A (es)
GR (1) GR3021300T3 (es)
HU (1) HUT68879A (es)
IL (2) IL107315A0 (es)
MX (1) MX9305196A (es)
MY (1) MY131384A (es)
NO (1) NO304375B1 (es)
NZ (1) NZ248360A (es)
SG (1) SG50627A1 (es)
SK (1) SK116693A3 (es)
TW (1) TW272973B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550139A (en) * 1994-01-03 1996-08-27 The Wichita State University Serine protease inhibitors
DE4427998A1 (de) * 1994-08-08 1996-02-15 Basf Ag Saccharinderivate
DE4427997A1 (de) * 1994-08-08 1996-02-15 Basf Ag 5-Hydroxypyrazol-4-yl-carbonyl-substituierte Saccharinderivate
DE4427995A1 (de) * 1994-08-08 1996-02-15 Basf Ag Saccharinderivate
US5556909A (en) * 1994-12-02 1996-09-17 Sanofi Winthrop Inc. Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
KR20000076083A (ko) * 1997-03-10 2000-12-26 스타르크, 카르크 사카린-5-카르보닐시클로헥산-1,3,5-트리온 유도체, 및 그의 제법 및 제초제로서의 용도
US6420401B1 (en) 1997-08-22 2002-07-16 Wichita State University 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
JP2003508480A (ja) * 1999-09-10 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 酵素インヒビター
MY147790A (en) * 2005-04-28 2013-01-31 Takeda Pharmaceutical Stable emulsion composition
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
KR102652866B1 (ko) 2017-04-06 2024-04-02 엥방티바 Ｙａｐ/ｔａｚ-ｔｅａｄ 상호작용의 억제제인 신규 화합물 및 악성 중피종의 치료에서의 이들의 용도
EP3632908A1 (en) 2018-10-02 2020-04-08 Inventiva Inhibitors of the yap/taz-tead interaction and their use in the treatment of cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3002884A (en) * 1959-04-15 1961-10-03 Rohm & Haas Horticultural process with n-halomethyl-1,2-benzisothiazolin - 3 - one-1,1-dioxides for controlling fungus diseases
US3314960A (en) * 1964-08-25 1967-04-18 American Home Prod Benzisothiazol glutarimides
FR1451417A (fr) * 1965-07-15 1966-01-07 Roussel Uclaf Nouveaux esters d'acides cycliques et leur procédé de préparation
JPS4835457A (es) * 1971-09-02 1973-05-24
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4263393A (en) * 1979-09-06 1981-04-21 Eastman Kodak Company Novel electron donor precursors and photographic element containing them
EP0026791B1 (en) * 1979-10-08 1984-05-02 Merck & Co. Inc. 2-aryl-1,2-benzisothiazolinone-1,1-dioxides and pharmaceutical compositions containing them
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4363865A (en) * 1981-03-04 1982-12-14 Eastman Kodak Company Imido methyl blocked photographic dyes and dye releasing compounds
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
US4623645A (en) * 1983-04-18 1986-11-18 Merck & Co., Inc. Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents
US4547371A (en) * 1983-04-18 1985-10-15 Merck & Co., Inc. Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
US4659855A (en) * 1983-05-09 1987-04-21 Georgia Tech Research Corporation Aryl sulfonyl fluoride compounds
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
JPH04507095A (ja) * 1989-05-04 1992-12-10 サノフィ 蛋白分解酵素阻害剤として有用なサッカリン誘導体及びその製造
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
FR2659327A1 (fr) * 1990-03-08 1991-09-13 Centre Nat Rech Scient Derives du benzisothiazolinone-1-dioxyde, utilisables comme inhibiteurs des elastases.
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW282463B (es) * 1991-11-15 1996-08-01 Sterling Winthrop Inc
TW226016B (es) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Also Published As

Publication number Publication date
FI934675A0 (fi) 1993-10-22
NO933817L (no) 1994-04-25
JPH06211849A (ja) 1994-08-02
IL107315A (en) 1999-03-12
EP0594257A1 (en) 1994-04-27
NZ248360A (en) 1995-08-28
SK116693A3 (en) 1995-02-08
TW272973B (es) 1996-03-21
CZ221093A3 (en) 1994-05-18
NO933817D0 (no) 1993-10-22
FI934675A (fi) 1994-04-24
IL107315A0 (en) 1994-01-25
AU4452693A (en) 1994-05-05
NO304375B1 (no) 1998-12-07
DK0594257T3 (da) 1996-11-11
EP0594257B1 (en) 1996-07-10
HUT68879A (en) 1995-08-28
CA2105731A1 (en) 1994-04-24
GR3021300T3 (en) 1997-01-31
ATE140227T1 (de) 1996-07-15
DE69303573D1 (de) 1996-08-14
AU679446B2 (en) 1997-07-03
ES2092751T3 (es) 1996-12-01
HU9303009D0 (en) 1994-01-28
SG50627A1 (en) 1998-07-20
MY131384A (en) 2007-08-30
DE69303573T2 (de) 1997-02-27
KR940009183A (ko) 1994-05-20
US5306818A (en) 1994-04-26

Similar Documents

Publication Publication Date Title
FI906438A (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
ES2118283T3 (es) Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos.
DE69123124T2 (de) Dihydro-Isoquinolinderivate
NO924915L (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
DK543787D0 (da) Antibakterielle midler
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
MX9305196A (es) Novedosos 2-sacarinilmetil aril carboxilatos utiles como inhibidores de enzima proteolitica y composiciones y metodos de su uso.
BR9408392A (pt) Derivados de ácidos arilacéticos e sua utilização como fungicidas
FI92198C (fi) Menetelmä valmistaa farmakologisesti arvokkaita 2-(RS)-substituoituja 2,3-dihydro-5-oksi-4,6,7-trimetyylibentsofuraaneja
MY131053A (en) 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ES2109530T3 (es) Derivados de acidos fenil-ciclohexano-carboxilicos heterotriciclicamente sustituidos.
FI932691A (fi) Nya benzyl- och benzhydrylalkoholer
FI842533A (fi) Hexahydropyrrolo/2,1-a/isokinolin- derivat.
DK305182A (da) Biologisk aktive heterobicycliske hydroximidater og thiolhydroximidater samt carbamatesterderivater deraf
NO924701L (no) Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees